4570.T Stock - Immuno-Biological Laboratories Co., Ltd.
Unlock GoAI Insights for 4570.T
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $969.53M | $816.70M | $794.62M | $647.58M | $602.75M |
| Gross Profit | $628.34M | $517.29M | $526.71M | $376.70M | $346.86M |
| Gross Margin | 64.8% | 63.3% | 66.3% | 58.2% | 57.5% |
| Operating Income | $209.35M | $104.30M | $58.37M | $-122,219,000 | $-240,984,000 |
| Net Income | $249.05M | $186.69M | $-289,731,000 | $-258,767,000 | $-318,827,000 |
| Net Margin | 25.7% | 22.9% | -36.5% | -40.0% | -52.9% |
| EPS | $26.74 | $20.05 | $-31.11 | $-27.78 | $-34.23 |
Immuno-Biological Laboratories Co., Ltd. engages in the research, development, manufacturing, and supply of various immunological research reagents worldwide. The company offers ELILSA, an assay kit to quantitatively measure targeted substances; and support research services on Alzheimer's disease, metabolic syndrome, and cancer, as well as customized services for production of customized antibodies and development of ELISA systems. It also provides LipoSEARCH, a customized services for profiling and analyzing of lipoprotein through gel-filtration high performance liquid chromatography method that can profile various clinical samples, such as tiny plasma or serum samples from both small animals and human beings for broad range of research fields including lipid metabolism, development of drugs for life-style related diseases, development of functional supplemental foods, and clinical studies. In addition, the company offers LipoTEST, a support tool for diagnostic and health checks at animal clinics; and customized biomarker testing services for Life-style related diseases. Further, it operates protein production business using transgenic silkworms for manufacturing of antibodies for research reagents and diagnostic products; human collagen for cosmetic materials; development of proteins for use in drugs; and other proteins production. The company was incorporated in 1982 and is headquartered in Fujioka, Japan.
Visit WebsiteEarnings History & Surprises
4570.TEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 13, 2025 | — | $8.66 | — | — |
Q3 2025 | Aug 8, 2025 | — | $6.54 | — | — |
Q2 2025 | May 14, 2025 | — | $12.42 | — | — |
Q1 2025 | Feb 10, 2025 | — | $6.64 | — | — |
Q4 2024 | Nov 11, 2024 | — | $2.16 | — | — |
Q3 2024 | Aug 8, 2024 | — | $5.51 | — | — |
Q2 2024 | May 14, 2024 | — | $17.83 | — | — |
Q1 2024 | Feb 2, 2024 | — | $-0.67 | — | — |
Q4 2023 | Nov 2, 2023 | — | $1.69 | — | — |
Q3 2023 | Aug 7, 2023 | — | $1.20 | — | — |
Q2 2023 | May 12, 2023 | — | $-22.90 | — | — |
Q1 2023 | Feb 6, 2023 | — | $6.41 | — | — |
Q4 2022 | Nov 4, 2022 | — | $-8.29 | — | — |
Q3 2022 | Aug 5, 2022 | — | $-6.33 | — | — |
Q2 2022 | May 13, 2022 | — | $-1.64 | — | — |
Q1 2022 | Feb 4, 2022 | — | $-4.74 | — | — |
Q4 2021 | Nov 5, 2021 | — | $-9.51 | — | — |
Q3 2021 | Aug 6, 2021 | — | $-11.89 | — | — |
Q2 2021 | May 14, 2021 | — | $-1.61 | — | — |
Q1 2021 | Feb 12, 2021 | — | $-7.86 | — | — |
Latest News
Frequently Asked Questions about 4570.T
What is 4570.T's current stock price?
What is the analyst price target for 4570.T?
What sector is Immuno-Biological Laboratories Co., Ltd. in?
What is 4570.T's market cap?
Does 4570.T pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to 4570.T for comparison